Multiplex Assay Kit for Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay)

BALP; BSAP; HOPS; AP-TNAP; TNSALP; Bone Alkaline Phosphatase; Alkaline Phosphatase,Tissue-Nonspecific Isozyme; Alkaline Phosphatase, Liver/Bone/Kidney

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 97-105 102
EDTA plasma(n=5) 90-98 95
heparin plasma(n=5) 80-103 99
sodium citrate plasma(n=5) 87-94 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-89% 96-103% 83-97% 82-93%
EDTA plasma(n=5) 79-104% 85-101% 83-101% 81-99%
heparin plasma(n=5) 81-102% 89-104% 79-94% 78-91%
sodium citrate plasma(n=5) 98-105% 80-98% 78-103% 95-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:ALPL) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Materials Science: Materials in Medicine Osteopenic bone cell response to strontium-substituted hydroxyapatite SpringerLink: n8233337w171v451
Osteoporosis International Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation PubMed: 23400250
Journal of Applied Toxicology Chronic exposure to low concentrations of strontium 90 affects bone physiology but not the hematopoietic system in mice Wiley: Source
Acta Pharmacologica Sinica The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model Pubmed:25544359
Biomedical Materials Enhanced differentiation of osteoblastic cells on novel chitosan/β-1, 3-glucan/bioceramic scaffolds for bone tissue regeneration Pubmed:25586067
Pharmacology Effect of Mirtazapine on Rat Bone Tissue after Orchidectomy PubMed: 25871861
J Biomed Mater Res A. New method for the fabrication of highly osteoconductive β-1,3-glucan/HA scaffold for bone tissue engineering: Structural, mechanical, and biological characterization. Pubmed:27239050
J Bone Miner Metab MiR-142-5p promotes bone repair by maintaining osteoblast activity Pubmed:27085967
Journal of Biomedical Materials Research New method for the fabrication of highly osteoconductive β‐1, 3‐glucan/HA scaffold for bone tissue engineering: Structural, mechanical, and biological … doi:10.1002
Journal of Bone and Mineral Metabolism MiR‑142‑5p promotes bone repair by maintaining osteoblast activity pubmed:27085967
Scientific Reports Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma Pubmed:30038263
International Journal of Molecular Sciences  Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo Pubmed:29562730
Pharmacology Effects of Amlodipine on Bone Metabolism in Orchidectomised Spontaneously Hypertensive Rats Pubmed:29898457
Experimental and Therapeutic Medicine Combination therapy with BMP‑2 and psoralen enhances fracture healing in ovariectomized mice 10.3892:etm.2018.6353
American Journal of Translational Research Long non-coding RNA SNHG7 promotes the fracture repair through negative modulation of miR-9
The effect of low temperature atmospheric nitrogen plasma on MC3T3-E1 preosteoblast proliferation and differentiation in vitro
International Journal of Biomaterials Bovine Hydroxyapatite-Based Bone Scaffold with Gentamicin Accelerates Vascularization and Remodeling of Bone Defect 34104195
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB091Hu01 Recombinant Alkaline Phosphatase, Tissue-nonspecific (ALPL) Positive Control; Immunogen; SDS-PAGE; WB.
APB091Hu61 Active Alkaline Phosphatase, Tissue-nonspecific (ALPL) Cell culture; Activity Assays.
EPB091Hu61 Eukaryotic Alkaline Phosphatase, Tissue-nonspecific (ALPL) Positive Control; Immunogen; SDS-PAGE; WB.
PAB091Hu01 Polyclonal Antibody to Alkaline Phosphatase, Tissue-nonspecific (ALPL) WB; IHC; ICC; IP.
MAB091Hu23 Monoclonal Antibody to Alkaline Phosphatase, Tissue-nonspecific (ALPL) WB; IHC; ICC; IP.
MAB091Hu21 Monoclonal Antibody to Alkaline Phosphatase, Tissue-nonspecific (ALPL) WB; IHC; ICC; IP.
MAB091Hu24 Monoclonal Antibody to Alkaline Phosphatase, Tissue-nonspecific (ALPL) WB; IHC; ICC; IP.
MAB091Hu22 Monoclonal Antibody to Alkaline Phosphatase, Tissue-nonspecific (ALPL) WB,IHC
SEB091Hu ELISA Kit for Alkaline Phosphatase, Tissue-nonspecific (ALPL) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB091Hu Multiplex Assay Kit for Alkaline Phosphatase, Tissue-nonspecific (ALPL) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.